<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362997">
  <stage>Registered</stage>
  <submitdate>5/09/2012</submitdate>
  <approvaldate>7/09/2012</approvaldate>
  <actrnumber>ACTRN12612000965808</actrnumber>
  <trial_identification>
    <studytitle>Does reducing intra-abdominal scar tissue formation after removal of a gastric band make subsequent obesity surgery quicker and safer?</studytitle>
    <scientifictitle>Can the Sprayable Adhesion Barrier SprayShield (Trademark) reduce operating time during laparoscopic sleeve gastrectomy in patients who have previously had laparoscopic removal of a gastric band?</scientifictitle>
    <utrn>U1111-1134-3424</utrn>
    <trialacronym>The SABROS (Sprayable Adhesion Barriers in Revisional Obesity Surgery) trial</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Post-operative, intra-abdominal adhesion formation</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Surgical techniques</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The intervention is performed at the end of the laparoscopic gastric band removal before removing all the laparoscopic ports.  It is a Polymer Kit containing two precursor solutions, a polyethylene glycol (PEG) ester trilysine amine solution and a borate buffer solution. These are mixed together causing the precursors to link forming a synthetic, absorbable, hydrogel adhesion barrier. The reconstituted Polymer Kit syringes are attached to an applicator to allow the polymer to be sprayed onto the operative field. Upon spraying, the polymer liquids mix and rapidly cross-link to form a thin, flexible, tissue adherent, hydrogel adhesion barrier.</interventions>
    <comparator>No treatment (patients undergo a standard laparoscopic gastric band removal without use of the intervention)</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Operative time of the laparoscopic sleeve gastrectomy (as calculated by blinded assessor on DVD)</outcome>
      <timepoint>Day of surgery</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Time taken to complete dissection during laparoscopic sleeve gastrectomy (as calculated by blinded assessor on DVD)</outcome>
      <timepoint>Day of surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Morbidity and mortality as assessed by patient case note review</outcome>
      <timepoint>30 days post-laparoscopic sleeve gastrectomy</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Density of adhesions encoutered during laparoscopic sleeve gastrectomy (as calculated by blinded assessor on DVD)</outcome>
      <timepoint>Day of surgery</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients undergoing a staged conversion of a gastric band to a laparoscopic sleeve gastrectomy who meet the following criteria:
1 Any sex
2 Aged over 18
3 Proficient at speaking and understanding written English
4 Ability to understand the consent process</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1 Band erosion as reason for gastric band removal
2 Previous major surgery with suspicion of pre-existing adhesions
3 Pregnant or lactating
4 Renal or  hepatic impairment
5 Known allergy to blue food colourings</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Central randomisation by computer</concealment>
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/10/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>52</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Michael Talbot</primarysponsorname>
    <primarysponsoraddress>Suite 3, Level 5 
St George Private Hospital 
1 South Street
Kogarah NSW 2217</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Covidien PLC</fundingname>
      <fundingaddress>166 Epping Road 
Lane Cove 
NSW 2066</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Dr William Hawkins</othercollaboratorname>
      <othercollaboratoraddress>Suite 3, Level 5 
St George Private Hospital 
1 South Street
Kogarah NSW 2217</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>A randomised trial to determine whether using a sprayable adhesion barrier onto the operative field during removal of a gastric band will make a future laparoscopic sleeve gastrectomy quicker and safer due to reduced scar formation where the gastric band used to be.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Bellberry</ethicname>
      <ethicaddress>229 Greenhill Road
Dulwich
South Australia 5065</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>9/08/2012</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Michael Talbot</name>
      <address>Upper GI Surgery
Suite 3, Level 5 
St George Private Hospital 
1 South Street
Kogarah NSW 2217</address>
      <phone>+61 2 9553 1120</phone>
      <fax />
      <email>michaelt@uppergisurgery.com.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Tania Matisan</name>
      <address>Upper GI Surgery
Suite 3, Level 5 
St George Private Hospital 
1 South Street
Kogarah NSW 2217</address>
      <phone>+61 2 9553 1120</phone>
      <fax />
      <email>TaniaM@uppergisurgery.com.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr William Hawkins</name>
      <address>Upper GI Surgery
Suite 3, Level 5 
St George Private Hospital 
1 South Street
Kogarah NSW 2217</address>
      <phone>+61 406 997993</phone>
      <fax />
      <email>whawkins@doctors.org.uk</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>